| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2080645 | Drug Discovery Today | 2009 | 4 Pages |
Abstract
Leading pharmaceutical companies are increasingly making biotech acquisitions to help them refill their pipelines, but what makes a good acquisition target and what will be the impact of the present financial crisis on deals.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Nafees N. Malik,